Arkolith/Insider Trading/BDSX/Form 4

O'Kane Kieran

Chief Commercial OfficerBIODESIX INC (BDSX) · full profile →Form 4 · filed Feb 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2026Sell(S)535$12.78$7K10K
Feb 20, 2026Option exercise(M)1K——10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2026Option exercise(M)1K—$04K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000986) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML